Insider filing · REGN
Michael S Brown
Director
profile →
Regeneron Pharmaceuticals, Inc.
REGN · Healthcare · 35 filings in 24 months
ticker →
Michael S Brown sold $1.7M of Regeneron Pharmaceuticals (REGN)
Executed Oct 30, disclosed Nov 3, 4 days later.
Value, as filed
$1.7M
1,929 sh × $875.00
Executed
Oct 30
the trade date, as filed
Disclosed
Nov 3
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MBMichael S Brown (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $1.7M of REGN (1,929 sh × $875.00, as filed), executed Oct 30.
The name
REGNHealthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→